Spots Global Cancer Trial Database for apoptosis
Every month we try and update this database with for apoptosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer | NCT01220999 | Colorectal Neop... | CS-1008 | 18 Years - | Ludwig Institute for Cancer Research | |
| Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects | NCT00762801 | Healthy | 18 Years - | University of North Texas Health Science Center | ||
| Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA | NCT00510692 | Familial Adenom... FAP | Eicosapentanoic... Endoscopy Biopsies taken Placebo | 18 Years - | S.L.A. Pharma AG | |
| A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors | NCT01664000 | Solid Tumors | thioureidobutyr... | 18 Years - | Cellceutix Corporation | |
| Atorvastatin Before Prostatectomy and Prostate Cancer | NCT01821404 | Prostatic Neopl... | Atorvastatin Placebo | 40 Years - 80 Years | Tampere University Hospital | |
| Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma | NCT00626704 | Locally Advance... Sarcoma Soft Tissue Sar... | AMG 655 Placebo Doxorubicin | 18 Years - | Amgen | |
| Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell Line | NCT03288298 | Tongue Neoplasm... Carcinoma | luteolin nano-luteolin | - | Cairo University | |
| Use of the MiCK Assay for Apoptosis in AML | NCT00286845 | Leukemia, Myelo... | Standard Chemot... | 18 Years - | Pierian Biosciences | |
| Safety and Efficacy of LCL161 in Patients With Solid Tumors | NCT01098838 | Advanced Solid ... | LCL161 | 18 Years - | Novartis | |
| Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies | NCT00037817 | Advanced Esopha... Primary Small C... Non-Small-Cell ... Pleural Mesothe... Cancers of Non-... | Decitabine Depsipeptide Celecoxib | 18 Years - 65 Years | National Institutes of Health Clinical Center (CC) | |
| Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS) | NCT00700206 | Myelodysplastic... | Ezatiostat Hydr... | 18 Years - | Telik | |
| UCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell Lymphomas | NCT00082017 | Lymphoma, Large... Lymphoma, T-Cel... | UCN-01 (7-hydro... | 12 Years - | National Institutes of Health Clinical Center (CC) | |
| Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell Line | NCT03288298 | Tongue Neoplasm... Carcinoma | luteolin nano-luteolin | - | Cairo University | |
| Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome | NCT01459159 | Myelodysplastic... | ezatiostat hydr... | 18 Years - | Telik | |
| Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma | NCT00626704 | Locally Advance... Sarcoma Soft Tissue Sar... | AMG 655 Placebo Doxorubicin | 18 Years - | Amgen | |
| Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation | NCT02828878 | Hematological M... | Allogeneic MPBC... | 18 Years - 70 Years | Cellect Biotechnology | |
| Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA | NCT00510692 | Familial Adenom... FAP | Eicosapentanoic... Endoscopy Biopsies taken Placebo | 18 Years - | S.L.A. Pharma AG | |
| Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors | NCT02723864 | Neoplasms | Veliparib + VX-... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| TRC105 for Liver Cancer That Has Not Responded to Sorafenib | NCT01375569 | Hepatocellular ... Hepatocellular ... Carcinoma, Hepa... | TRC105 | 18 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
| Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics | NCT00612560 | Breast Cancer | Anastrozole flaxseed Placebo | 18 Years - 85 Years | Roswell Park Cancer Institute | |
| Curcumin Supplementation in Cervical Cancer | NCT06080841 | Locally Advance... | Curcumin Curcumin + Pipe... | 18 Years - | National Institute of Cancerología | |
| Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa | NCT00432913 | Adenomatous Pol... | Eicosapentaenoi... Endoscopy Biopsies taken Clinical chemis... Haematology Physical examin... Vital signs Urine pregnancy... Completion of p... | 18 Years - | S.L.A. Pharma AG | |
| Postpartum Uterine Regression | NCT00341848 | Uterine Leiomyo... | 18 Years - 45 Years | National Institutes of Health Clinical Center (CC) | ||
| Study of INBRX-109 in Conventional Chondrosarcoma | NCT04950075 | Conventional Ch... | INBRX-109 Placebo | 18 Years - 85 Years | Inhibrx Biosciences, Inc | |
| Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein | NCT00048880 | Neoplasms | HeFi-1 Monoclon... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects | NCT00762801 | Healthy | 18 Years - | University of North Texas Health Science Center | ||
| Dietary Intervention With High Phenolic EVOO in CLL | NCT04215367 | Chronic Lymphoc... | High phenolic E... No High phenoli... | 54 Years - 84 Years | University of Peloponnese | |
| Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate in Cervical Cancer | NCT06147960 | Cancer of Cervi... Apoptosis | Immunohistochem... | 18 Years - | Centre Hospitalier Universitaire de Nīmes | |
| 9-ING-41 in Patients With Advanced Cancers | NCT03678883 | Cancer Pancreatic Canc... Sarcoma Renal Cancer Refractory Canc... Refractory Neop... Refractory Non-... Pancreatic Aden... Resistant Cance... Neoplasm Metast... Neoplasm of Bon... Neoplasm, Breas... Neoplasm of Lun... Neoplasms,Color... Neoplasms Pancr... Malignant Gliom... Malignancies Malignancies Mu... Bone Metastases Bone Neoplasm Bone Cancer Pancreas Cancer Pancreatic Neop... Breast Neoplasm... Acute T Cell Le... | 9-ING-41 Gemcitabine - 2... Doxorubicin. Lomustine Carboplatin. Nab paclitaxel. Paclitaxel. Gemcitabine - 2... Irinotecan | 18 Years - | Actuate Therapeutics Inc. | |
| FishGastro Study: Fish Consumption and Gastro-Intestinal Health | NCT00145015 | Colorectal Canc... Ulcerative Coli... Polyps | Increased dieta... | 18 Years - 80 Years | Quadram Institute Bioscience | |
| Demographics, Clinical Outcomes, and Physician Attitudes in Patients Who Have Received The MiCK Assay (CorrectChemo) | NCT02137811 | Cancer | MICK Assay | - | Pierian Biosciences | |
| Study of PRoliferation and Apoptosis in Rectal Cancer, Predictive & Prognostic biOmarkers: Histopathology and Imaging | NCT02486094 | Neoplasms Colorectal Neop... Rectal Diseases Gastrointestina... | 18 Years - | Royal Marsden NHS Foundation Trust | ||
| Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat | NCT00791011 | Hodgkin's Lymph... Low Grade Lymph... Lymphoma Mantle Cell Lym... Non-Hodgkin's L... Diffuse Large C... | AMG 655 Vorinostat Bortezomib | 18 Years - | Amgen | |
| Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer | NCT00816244 | Breast Cancer Postmenopausal | Atorvastatin | 18 Years - | Lund University Hospital | |
| Atorvastatin Before Prostatectomy and Prostate Cancer | NCT01821404 | Prostatic Neopl... | Atorvastatin Placebo | 40 Years - 80 Years | Tampere University Hospital | |
| Dietary Intervention With High Phenolic EVOO in CLL | NCT04215367 | Chronic Lymphoc... | High phenolic E... No High phenoli... | 54 Years - 84 Years | University of Peloponnese | |
| A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chronic Lymphocytic Leukemia (CLL) | NCT01087151 | Chronic Lymphoc... | ABT-263 rituximab | 18 Years - | Genentech, Inc. | |
| Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast Cancer | NCT00525759 | Breast Cancer | 5-FU, Epirubici... 5-FU, Epirubici... | 18 Years - | Sheffield Teaching Hospitals NHS Foundation Trust | |
| Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma | NCT00068146 | Lymphoprolifera... Lymphoma | 8 Years - | National Institutes of Health Clinical Center (CC) | ||
| Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis | NCT00243685 | Breast Neoplasm... Lung Neoplasms Ovarian Neoplas... Sarcoma, Soft T... | Laboratory Assa... Mick Assay | 18 Years - 85 Years | Pierian Biosciences | |
| Enhancing Effect on Tumour Apoptosis With the Use of Pentoxifylline in Patients With Hodgkin Lymphoma | NCT05490953 | Hodgkin Lymphom... | Pentoxifylline Placebo | 6 Years - 35 Years | University of Guadalajara | |
| Demographics, Clinical Outcomes, and Physician Attitudes in Patients Who Have Received The MiCK Assay (CorrectChemo) | NCT02137811 | Cancer | MICK Assay | - | Pierian Biosciences | |
| Safety and Efficacy of LCL161 in Patients With Solid Tumors | NCT01098838 | Advanced Solid ... | LCL161 | 18 Years - | Novartis | |
| Expression Analysis of the COPB 2 and Bcl-2 in Early Stages of Endometrial Carcinoma | NCT05951426 | Endometrial Car... | 1.hysterectomy ... | - | Clinical Center Kragujevac | |
| UCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell Lymphomas | NCT00082017 | Lymphoma, Large... Lymphoma, T-Cel... | UCN-01 (7-hydro... | 12 Years - | National Institutes of Health Clinical Center (CC) | |
| TRC105 for Liver Cancer That Has Not Responded to Sorafenib | NCT01375569 | Hepatocellular ... Hepatocellular ... Carcinoma, Hepa... | TRC105 | 18 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
| Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects | NCT00762801 | Healthy | 18 Years - | University of North Texas Health Science Center | ||
| Dietary Intervention With High Phenolic EVOO in CLL | NCT04215367 | Chronic Lymphoc... | High phenolic E... No High phenoli... | 54 Years - 84 Years | University of Peloponnese | |
| Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein | NCT00048880 | Neoplasms | HeFi-1 Monoclon... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum | NCT00094978 | Carcinoma, Smal... Carcinoma, Non-... Esophageal Neop... Mesothelioma | Depsipeptide Flavopiridol (a... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component) | NCT00320827 | Malignancies Lymphoma | CS-1008 (humani... | 18 Years - | Daiichi Sankyo | |
| Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer | NCT00816244 | Breast Cancer Postmenopausal | Atorvastatin | 18 Years - | Lund University Hospital | |
| A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation in Patients With Chronic Lymphocytic Leukemia (CLL) | NCT01463852 | Chronic Lymphoc... | vincristine | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Safety and Efficacy of LCL161 in Patients With Solid Tumors | NCT01098838 | Advanced Solid ... | LCL161 | 18 Years - | Novartis | |
| Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers | NCT01367288 | Locally Advance... Ductal Histolog... Without Her 2 O... | Zometa + Neoadj... Neoadjuvant the... | 18 Years - | Hospices Civils de Lyon | |
| Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat | NCT00791011 | Hodgkin's Lymph... Low Grade Lymph... Lymphoma Mantle Cell Lym... Non-Hodgkin's L... Diffuse Large C... | AMG 655 Vorinostat Bortezomib | 18 Years - | Amgen | |
| Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS) | NCT00700206 | Myelodysplastic... | Ezatiostat Hydr... | 18 Years - | Telik | |
| FishGastro Study: Fish Consumption and Gastro-Intestinal Health | NCT00145015 | Colorectal Canc... Ulcerative Coli... Polyps | Increased dieta... | 18 Years - 80 Years | Quadram Institute Bioscience |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
